Laboratory Infection
Showing 1 - 25 of >10,000
Coronavirus Disease 19 (COVID-19) Convalescent Plasma
Active, not recruiting
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Biospecimen Collection
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Dasatinib Anhydrous, Placebo Administration)
Withdrawn
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Dasatinib Anhydrous
- Placebo Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,
Withdrawn
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- +8 more
- Ibrutinib
- Quality-of-Life Assessment
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 2, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Performances of DendrisCHIP®OA in Bone and Joint Infections
Not yet recruiting
- Bone Infection
- +2 more
-
Boulogne-Billancourt, FranceLaboratory of microbiology, Ambroise Paré hospital - APHP
Nov 13, 2023
Postoperative Complications, Antibiotic Reaction, Antibiotic Side Effect Trial in Novi Sad (Moxifloxacin 400 mg Oral Tablet,
Active, not recruiting
- Postoperative Complications
- +6 more
- Moxifloxacin 400 mg Oral Tablet
- +2 more
-
Novi Sad, Vojvodina, SerbiaDental Clinic of Vojvodina, Faculty of Medicine, University of N
Jun 14, 2022
Mycoplasma Genitalium Infection and Associated Antimicrobial
Not yet recruiting
- STI
- Mycoplasma Genitalium Infection
- self-sampling kits for STI testing in the laboratory
-
Hong Kong, Hong Kong, China, Hong KongThe Chinese University of Hong Kong
Mar 16, 2023
Infection Trial in Otwock (Knee arthroplasty)
Recruiting
- Infection
- Knee arthroplasty
-
Otwock, Mazowieckie, PolandDepartment of Orthopaedics and Traumatology, Postgraduate Center
Jul 13, 2022
Infection, Bacterial, Wound Infection, Wound Infection, Surgical Trial in Hull (DACC-Coated Post Operative Dressing)
Recruiting
- Infection, Bacterial
- +4 more
- DACC-Coated Post Operative Dressing
-
Hull, East Riding Of Yorkshire, United KingdomAcademic Vascular Surgery Unit, Vascular Laboratory, Alderson Ho
Feb 1, 2023
Myocardial Disease Trial in Milano, Roma (Sample blood)
Active, not recruiting
- Myocardial Disease
- Sample blood
-
Milano, Italy
- +1 more
Feb 17, 2023
Aplastic Anemia, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Ibrutinib)
Active, not recruiting
- Aplastic Anemia
- +6 more
- Best Practice
- Ibrutinib
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022
Covid19 Trial in Philadelphia (Cytotoxic T Lymphocytes)
Active, not recruiting
- Covid19
- Cytotoxic T Lymphocytes
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 15, 2022
Evaluation of Infection in Obstructing Urolithiasis
Active, not recruiting
- Kidney Stone
- +4 more
- Initial clinical and laboratory evaluation
-
Dallas, Texas
- +1 more
Sep 29, 2022
Immune Responses to COVID-19 Infection or Vaccination
Recruiting
- COVID-19
- Laboratory assessment of antibody profiles
-
Richmond, VirginiaAditxt
May 17, 2022
COVID-19 Respiratory Infection Trial in Sohag (laboratory test)
Completed
- COVID-19 Respiratory Infection
- laboratory test
-
Sohag, EgyptSohag University
Oct 24, 2022
Laboratory Confirmed SARS-CoV-2 Infection Without Symptoms Trial in Lambaréné (Wantai kit Elisa)
Recruiting
- Laboratory Confirmed SARS-CoV-2 Infection Without Symptoms
- Wantai kit Elisa
-
Lambaréné, GabonCentre de Recherches Medicales de Lambarene
Jul 26, 2022
Bronchial Asthma and COVID-19 Infection in Adults: Clinical and
Completed
- Asthma
- COVID-19
- no intervention
-
Riyad, Saudi ArabiaRAFA medical centre
Dec 18, 2021
Acute and Lasting Cardiac Effects of Influenza Infection
Recruiting
- Influenza
- Cardiovascular Complication
-
Copenhagen, Denmark
- +1 more
Feb 21, 2022
COVID-19 Trial in Boston (vitamin D, Placebo)
Active, not recruiting
- COVID-19
- vitamin D
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 25, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Baricitinib, Hydroxychloroquine, Placebo
Terminated
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Baricitinib
- +2 more
-
Los Angeles, California
- +1 more
May 21, 2021